Monday, 13 February 2017

"Epigenetic pathways as targets in human disease", 16 February

This week's Hudson seminar will be held Thursday 16th February from 12.00-1.00pm at TRF Building, Level 2 Seminar rooms 1 & 2.

Our speaker will be Professor Shelley Berger, Daniel S. Och University Professor at University of Pennsylvania and Director of Epigenetics Institute, Penn School of Medicine. 

A light lunch and refreshments will follow the presentation.

Shelley Berger, Ph.D., is engaged in studies of chromatin and epigenetic regulation of the eukaryotic genome. Dr. Berger’s lab has become increasingly focused on the study of mammalian biology and human diseases, including cancer and other diseases associated with aging, as well as epigenetic control of learning, memory and behavior. The lab has been published in high impact journals, such as Cell, Nature, Science, and Genes & Development. Her work on epigenetics of behavior has been covered in The New York Times and The New Yorker. Dr. Berger is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Association for Advancement of Science.

No comments:

Post a Comment